HIV vaccine design and the neutralizing antibody problem (original) (raw)

Nature Immunology volume 5, pages 233–236 (2004)Cite this article

Eliciting broadly neutralizing antibodies to human immunodeficiency virus could bring closer the goal of a successful AIDS vaccine. Here the International AIDS Vaccine Initiative Neutralizing Antibody Consortium discusses current approaches to overcome the problems faced.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Figure 1: A model of the HIV-1 envelope spike showing the location of epitopes recognized by broadly neutralizing mAbs.

References

  1. Wyatt, R. & Sodroski, J. Science 280, 1884–1888 (1998).
    Article CAS Google Scholar
  2. Parren, P.W. & Burton, D.R. Adv. Immunol. 77, 195–262 (2001).
    Article CAS Google Scholar
  3. Johnson, W.E. & Desrosiers, R.C. Annu. Rev. Med. 53, 499–518 (2002).
    Article CAS Google Scholar
  4. Saphire, E.O. et al. Science 293, 1155–1159 (2001).
    Article CAS Google Scholar
  5. Calarese, D.A. et al. Science 300, 2065–2071 (2003).
    Article CAS Google Scholar
  6. Zwick, M.B. et al. J. Virol. 75, 10892–10905 (2001).
    Article CAS Google Scholar
  7. Stanfield, R.L., Gorny, M.K., Williams, C., Zolla-Pazner, S. & Wilson, I.A. Structure (in the press).
  8. Sharon, M. et al. Structure (Camb) 11, 225–236 (2003).
    Article CAS Google Scholar
  9. Proudfoot, A.E. et al. J. Biol. Chem. 276, 10620–10626 (2001).
    Article CAS Google Scholar
  10. Labrijn, A.F. et al. J. Virol. 77, 10557–10565 (2003).
    Article CAS Google Scholar
  11. Choe, H. et al. Cell 114, 161–170 (2003).
    Article CAS Google Scholar
  12. Golding, H. et al. J. Virol. 76, 6780–6790 (2002).
    Article CAS Google Scholar
  13. Sanders, R.W. et al. J. Virol. 76, 8875–8889 (2002).
    Article CAS Google Scholar
  14. Yang, X., Wyatt, R. & Sodroski, J. J. Virol. 75, 1165–1171 (2001).
    Article CAS Google Scholar
  15. Grundner, C., Mirzabekov, T., Sodroski, J. & Wyatt, R. J. Virol. 76, 3511–3521 (2002).
    Article CAS Google Scholar
  16. Srivastava, I.K. et al. J. Virol. 77, 11244–11259 (2003).
    Article CAS Google Scholar
  17. Pantophlet, R., Wilson, I.A. & Burton, D.R. J. Virol. 77, 5889–5901 (2003).
    Article CAS Google Scholar
  18. Fouts, T. et al. Proc. Natl. Acad. Sci. USA 99, 11842–11847 (2002).
    Article CAS Google Scholar
  19. Klausner, R.D. et al. Science 300, 2036–2039 (2003).
    Article CAS Google Scholar
  20. Kwong, P.D., Wyatt, R., Sattentau, Q.J., Sodroski, J. & Hendrickson, W.A. J. Virol. 74, 1961–1972 (2000).
    Article CAS Google Scholar
  21. Selvarajah, S. & Burton, D.R. Accelerating AIDS Vaccine Development: Challenges and Opportunities (eds. Kahn, P., Gust, P. & Koff, W.) (Horizon Scientific Press, Norwich, UK, in the press).

Download references

Author information

Authors and Affiliations

  1. Departments of Immunology and Molecular Biology, Scripps Research Institute, La Jolla, California, USA
    Dennis R Burton
  2. Division of Microbiology, New England Regional Primate Research Center, Harvard Medical School, Southborough, Massachusetts, USA
    Ronald C Desrosiers
  3. Department of Pathology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Robert W Doms
  4. International AIDS Vaccine Initiative, New York, New York, USA
    Wayne C Koff
  5. Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, USA
    Peter D Kwong, Gary J Nabel & Richard T Wyatt
  6. Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, USA
    John P Moore
  7. Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA
    Joseph Sodroski
  8. Department of Molecular Biology and the Skaggs Institute for Chemical Biology, Scripps Research Institute, La Jolla, California, USA
    Ian A Wilson

Authors

  1. Dennis R Burton
    You can also search for this author inPubMed Google Scholar
  2. Ronald C Desrosiers
    You can also search for this author inPubMed Google Scholar
  3. Robert W Doms
    You can also search for this author inPubMed Google Scholar
  4. Wayne C Koff
    You can also search for this author inPubMed Google Scholar
  5. Peter D Kwong
    You can also search for this author inPubMed Google Scholar
  6. John P Moore
    You can also search for this author inPubMed Google Scholar
  7. Gary J Nabel
    You can also search for this author inPubMed Google Scholar
  8. Joseph Sodroski
    You can also search for this author inPubMed Google Scholar
  9. Ian A Wilson
    You can also search for this author inPubMed Google Scholar
  10. Richard T Wyatt
    You can also search for this author inPubMed Google Scholar

Corresponding authors

Correspondence toDennis R Burton or John P Moore.

Rights and permissions

About this article

Cite this article

Burton, D., Desrosiers, R., Doms, R. et al. HIV vaccine design and the neutralizing antibody problem.Nat Immunol 5, 233–236 (2004). https://doi.org/10.1038/ni0304-233

Download citation

This article is cited by